rs2296600

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000043.6(FAS):​c.506-71C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.4 in 1,605,568 control chromosomes in the GnomAD database, including 130,037 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 11402 hom., cov: 32)
Exomes 𝑓: 0.40 ( 118635 hom. )

Consequence

FAS
NM_000043.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.557

Publications

11 publications found
Variant links:
Genes affected
FAS (HGNC:11920): (Fas cell surface death receptor) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. Several alternatively spliced transcript variants have been described, some of which are candidates for nonsense-mediated mRNA decay (NMD). The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform. [provided by RefSeq, Mar 2011]
FAS Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autoimmune lymphoproliferative syndrome type 1
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-89010682-C-G is Benign according to our data. Variant chr10-89010682-C-G is described in ClinVar as Benign. ClinVar VariationId is 1291170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.487 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FASNM_000043.6 linkc.506-71C>G intron_variant Intron 5 of 8 ENST00000652046.1 NP_000034.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FASENST00000652046.1 linkc.506-71C>G intron_variant Intron 5 of 8 NM_000043.6 ENSP00000498466.1

Frequencies

GnomAD3 genomes
AF:
0.385
AC:
58543
AN:
151898
Hom.:
11403
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.333
Gnomad AMI
AF:
0.422
Gnomad AMR
AF:
0.377
Gnomad ASJ
AF:
0.482
Gnomad EAS
AF:
0.503
Gnomad SAS
AF:
0.455
Gnomad FIN
AF:
0.409
Gnomad MID
AF:
0.436
Gnomad NFE
AF:
0.395
Gnomad OTH
AF:
0.404
GnomAD4 exome
AF:
0.402
AC:
583941
AN:
1453550
Hom.:
118635
Cov.:
29
AF XY:
0.404
AC XY:
292301
AN XY:
723764
show subpopulations
African (AFR)
AF:
0.340
AC:
11320
AN:
33276
American (AMR)
AF:
0.352
AC:
15713
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.477
AC:
12440
AN:
26082
East Asian (EAS)
AF:
0.484
AC:
19165
AN:
39616
South Asian (SAS)
AF:
0.458
AC:
39465
AN:
86090
European-Finnish (FIN)
AF:
0.414
AC:
22065
AN:
53342
Middle Eastern (MID)
AF:
0.456
AC:
2628
AN:
5760
European-Non Finnish (NFE)
AF:
0.395
AC:
436369
AN:
1104618
Other (OTH)
AF:
0.412
AC:
24776
AN:
60104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
19939
39879
59818
79758
99697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13684
27368
41052
54736
68420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.385
AC:
58550
AN:
152018
Hom.:
11402
Cov.:
32
AF XY:
0.389
AC XY:
28941
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.333
AC:
13796
AN:
41456
American (AMR)
AF:
0.376
AC:
5743
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.482
AC:
1675
AN:
3472
East Asian (EAS)
AF:
0.503
AC:
2605
AN:
5180
South Asian (SAS)
AF:
0.457
AC:
2200
AN:
4818
European-Finnish (FIN)
AF:
0.409
AC:
4318
AN:
10546
Middle Eastern (MID)
AF:
0.435
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
0.395
AC:
26853
AN:
67958
Other (OTH)
AF:
0.401
AC:
848
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1858
3716
5575
7433
9291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.268
Hom.:
669
Bravo
AF:
0.382
Asia WGS
AF:
0.422
AC:
1464
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 68% of patients studied by a panel of primary immunodeficiencies. Number of patients: 65. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.49
DANN
Benign
0.62
PhyloP100
-0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296600; hg19: chr10-90770439; COSMIC: COSV58238139; COSMIC: COSV58238139; API